COVID-19 vaccine Australia

The government today announced $26.2 million in funding for the University of Queensland to develop a vaccine against chlamydia, which causes infertility and blindness if left untreated in males and females.

Health Minister Tanya Plibersek and Assistant Health Minister Mark Butler said this was the single largest investment into research for an infectious disease that is not a blood-borne virus or sexually transmitted disease. They said this vaccine would offer protection from infection with Chlamydia trachomatis (CT) by using two proteins on the surface of CT bacteria called MOMP (major outer membrane protein)and VIR (variable infectivity region). A successful vaccine is critical to combat these diseases.“An estimated 258,000 Australians currently have trachoma, with about 20,000 new cases each year. Australia has the highest rates of trachoma in the world” Ms Plibersek said.

The vaccine will be tested

Chlamydia affects more than 50% of Australian Aboriginal communities and is easily contracted through eye, nose or throat secretions.More than 820 women are diagnosed each day with pelvic inflammatory disease caused by chlamydia. The vaccine will be tested on 665 men and 650 women over 18 months at eight sites around Australia including Broome, Darwin, Perth metropolitan area, Alice Springs town camps and central Queensland Aboriginal communities. A second vaccine known as COVID-12 is being developed in partnership with Micromet Inc..

COVID 19 contains only one protein while COVID 12 contains both MOMP and a protein called human CD46.

A second chlamydia vaccine being developed in partnership with Micromet Inc. Contains only one protein while COVID 19 contains MOMP as well as a protein called human CD46. The UQ Centre for Clinical Research is working on the CHLAMYD-19 vaccine, with the Bill & Melinda Gates Foundation providing an initial $19 million grant in 2010 to develop the new vaccine.In addition, work is also being undertaken by Macquarie University and The University of New South Wales on developing vaccines against chlamydia and gonorrhoea (the latter is known as COVID 10). About 45% of global blindness cases are due to trachoma, the Federal Government says.UQ Centre for Clinical Research director Professor Peter Timms said his team was well-placed to lead this work following its success in developing a vaccine against Group B meningococcal disease, which is now available worldwide and has saved thousands of lives. (ARTICLE END)

http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2012-hunt017_chlamydia$26m-$2620021016133020PD6/$File/vaccine%20for%20chlamydia.pdf?Open&refNavID=HA1004_26\   MediaNews MIMS News Release – Health Minister Tanya Plibersek, COVID-19 vaccine Australia

http://www.health.gov.au/internet/ministers/publishing.NSF/Content/MEDIA-2011-HuntMed/$File/vaccineagainstchlamydiaindianowbuildingphasesoutwithtrialscurrentlyunderwayandphase2trialssoonto.pdf?Open&refNavID=ha1004_26  #medianews Department of Health – Vaccine against chlamydia in India now building phases out with trials currently underway and phase 2 trials soon to start again…

http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2012-hunt017_chlamydia$26m-$2620021016133020PD6/$File/vaccine%20for%20chlamydia.pdf?Open&refNavID=HA1004_26 #medianews MIMS News Release – Health Minister Tanya Plibersek, COVID-19 vaccine Australia

http://www.health.gov.au/internet/ministers/publishing.nsf/Content/MEDIA-2011-HuntMed/$File/vaccineagainstchlamydiaindianowbuildingphasesoutwithtrialscurrentlyunderwayandphase2trialssoonto.pdf?Open&refNavID=ha1004_26#medianews Department of Health – Vaccine against chlamydia in India now building phases out with trials currently underway and phase 2 trials soon to start again…

http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2012-hunt017_chlamydia$26m-$2620021016133020PD6/$File/vaccine%20for%20chlamydia.pdf?Open&refNavID=HA1004_26#medianews MIMS News Release – Health Minister Tanya Plibersek, COVID-19 vaccine Australia

http://www.sciencemag.org

Leave a Reply

Your email address will not be published.